187 related articles for article (PubMed ID: 26858129)
1. Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.
Sun Y; Yu W; Sturgis EM; Peng W; Lei D; Wei Q; Song X; Li G
BMC Cancer; 2016 Feb; 16():70. PubMed ID: 26858129
[TBL] [Abstract][Full Text] [Related]
2. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.
Lei D; Sturgis EM; Wang LE; Liu Z; Zafereo ME; Wei Q; Li G
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1484-91. PubMed ID: 20501759
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck.
Jin L; Sturgis EM; Zhang Y; Huang Z; Wei P; Guo W; Wang Z; Wei Q; Song X; Li G
Carcinogenesis; 2013 Jul; 34(7):1551-7. PubMed ID: 23508638
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck.
Wang Z; Sturgis EM; Zhang F; Lei D; Liu Z; Xu L; Song X; Wei Q; Li G
Mol Cancer; 2012 Mar; 11():17. PubMed ID: 22449259
[TBL] [Abstract][Full Text] [Related]
5. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
Zhang Y; Sturgis EM; Zafereo ME; Wei Q; Li G
Cancer; 2011 Mar; 117(6):1227-35. PubMed ID: 21381012
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
Lei D; Sturgis EM; Liu Z; Zafereo ME; Wei Q; Li G
Carcinogenesis; 2010 Feb; 31(2):222-7. PubMed ID: 19955391
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
[TBL] [Abstract][Full Text] [Related]
9. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck.
Zafereo ME; Sturgis EM; Aleem S; Chaung K; Wei Q; Li G
Cancer Prev Res (Phila); 2009 May; 2(5):432-9. PubMed ID: 19401526
[TBL] [Abstract][Full Text] [Related]
10. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck.
Li F; Sturgis EM; Zafereo ME; Liu Z; Wang LE; Wei Q; Li G
Int J Cancer; 2009 Dec; 125(11):2660-5. PubMed ID: 19585505
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.
Zhang Y; Sturgis EM; Huang Z; Zafereo ME; Wei Q; Li G
Cancer; 2012 Jan; 118(2):485-92. PubMed ID: 21717430
[TBL] [Abstract][Full Text] [Related]
12.
Costa EFD; Lima TRP; Lopes-Aguiar L; Nogueira GAS; Visacri MB; Quintanilha JCF; Pincinato EC; Calonga L; Mariano FV; Altemani AMAM; Altemani JMC; Moriel P; Chone CT; Ramos CD; Lima CSP
Tumour Biol; 2020 Jul; 42(7):1010428320938494. PubMed ID: 32628088
[TBL] [Abstract][Full Text] [Related]
13. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck.
Li F; Sturgis EM; Chen X; Zafereo ME; Wei Q; Li G
Cancer; 2010 May; 116(10):2350-9. PubMed ID: 20225330
[TBL] [Abstract][Full Text] [Related]
14. A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.
Guan X; Liu Z; Liu H; Yu H; Wang LE; Sturgis EM; Li G; Wei Q
FASEB J; 2013 Apr; 27(4):1404-12. PubMed ID: 23271051
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
Wang J; Gao J; Li Y; Zhao X; Gao W; Peng L; Yan D; Liu L; Li D; Wei L; Qi J; Zhou C
Gene; 2013 Jul; 524(2):193-6. PubMed ID: 23618817
[TBL] [Abstract][Full Text] [Related]
17. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
[TBL] [Abstract][Full Text] [Related]
18. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
Zafereo ME; Sturgis EM; Liu Z; Wang LE; Wei Q; Li G
Carcinogenesis; 2009 Jun; 30(6):997-1002. PubMed ID: 19369580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
